TITLE

COMMENTARY: Raloxifene produced both harms and benefits in postmenopausal women, with no reduction in cardiovascular disease risk

AUTHOR(S)
Thacker, Holly L.
PUB. DATE
November 2006
SOURCE
ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p73
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents the author's comments on whether raloxifene can produce both harms and benefits in postmenopausal women with no reduction in cardiovascular disease risk. Older women at high risk for cardiovascular events should not rely on raloxifene for chronic disease prevention. Women should be individually assessed for menopausal symptoms and risks for disease, then counseled regarding the known risks, benefits, and side effects of existing pharmacologic agents.
ACCESSION #
23245707

 

Related Articles

  • Anxious Hearts -- Anxiety and CVD. Greenfield, Russell H. // Alternative Medicine Alert;Jan2008, Vol. 11 Issue 1, p11 

    The article presents information on a study which determined whether panic attacks are associated with risk of cardiovascular morbidity and mortality and all-cause mortality in postmenopausal women. Subjects of the study include healthy postmenopausal women aging 51-83 years. The study concluded...

  • Survey: Older women unaware of cholesterol, heart disease risks.  // Geriatrics;Mar1991, Vol. 46 Issue 3, p19 

    The article reports that women aged 50 and older generally do not realize the risks they face from high cholesterol and heart disease, according to a Gallup survey. Only 15% of 501 women polled realized that heart disease was the number-one killer of women in their age group, and nearly one-half...

  • Midlife lipid changes found more related to the menopause than to ageing.  // Menopause International;Mar2010, Vol. 16 Issue 1, p2 

    The article focuses on a report from the Study of Women's Health Across the Nation (SWAN) released in the U.S. in 2010, revealing the impact of menopause on midlife lipid changes. It could not be confirmed whether menopause had an impact on a woman's risk of cardiovascular disease but the SWAN...

  • Perimenopausal Obesity. Keller, Colleen; Larkey, Linda; Distefano, Johanna K.; Boehm-Smith, Edna; Records, Kathie; Robillard, Alyssa; Veres, Sharry; Al-Zadjali, Manal; O'Brian, Anne-Marie // Journal of Women's Health (15409996);May2010, Vol. 19 Issue 5, p987 

    Obesity is recognized as one of the most important underlying risk factors for a wide variety of diseases, including heart disease and diabetes. Women are particularly prone to obesity, and approaches that address life transitions across the life span suggest that a number of factors may...

  • Assume Nothing. Cassidy, Catherine M. // Prevention;May2003, Vol. 55 Issue 5, p19 

    Presents observations from the editor with regard to the differences between men and women. Consideration of the assumption that women do not get heart disease; Use of hormone therapy for women; How National Women's Health Week is in May.

  • Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause. Rossouw, Jacque E.; Prentice, Ross L.; Manson, JoAnn E.; Wu, LieLing; Barad, David; Barnabei, Vanessa M.; Ko, Marcia; LaCroix, Andrea Z.; Margolis, Karen L.; Stefanick, Marcia L. // JAMA: Journal of the American Medical Association;4/4/2007, Vol. 297 Issue 13, p1465 

    The article discusses whether the effects of hormone therapy on the risk of cardiovascular disease in women vary by the age of the woman or the years since menopause began. The authors conducted a secondary analysis of the Women's Health Initiative randomized controlled trials of hormone therapy...

  • Folate 'could protect women from alcohol'. Polak, Monika // GP: General Practitioner;11/3/2003, p8 

    According to researchers in the U.S., folate could protect women against the detrimental effects of a high alcohol intake. Their study, which included data on more than 80,000 women, showed that the increased risk of major chronic disease associated with heavy drinking was largely diminished...

  • Socioeconomic differences in the burden of disease in Sweden. Ljung, Rickard; Peterson, Stefan; Hallqvist, Johan; Heimerson, Inger; Diderichsen, Finn // Bulletin of the World Health Organization;Feb2005, Vol. 83 Issue 2, p92 

    Objective We sought to analyse how much of the total burden of disease in Sweden, measured in disability-adjusted life years (DALYs), is a result of inequalities in health between socioeconomic groups. We also sought to determine how this unequal burden is distributed across different disease...

  • Those Fragile Hearts. Gupta, Sanjay; Gajilan, A. Chris // Time;2/10/2003, Vol. 161 Issue 6, p84 

    Reports that more women than men die from heart disease. Statistics released by the American Heart Association suggesting the number of men who die of heart disease has fallen in the 1980s and 1990s, but the number of women dying in that same time frame has increased; Survey conducted by Dr....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics